Orbit Discovery CEO, Neil Butt, will be attending the 3rd Annual Targeted Radiopharmaceuticals Summit in San Diego, CA from July 30th to August 1st.

Orbit has a growing presence in the targeted radiopharmceutical space thanks to its innovative peptide discovery platform.

Please connect with Neil if you are interested in applying Orbit’s platforms to your own company’s targetting peptide discovery efforts.




< Back